Telesis Bio Inc (TBIO) Earnings Report, Financial Results, Financial analysis

Telesis Bio Inc reported in the first quarter of 2023 net loss per share of $-0.37 compare to earnings per share of $0.23 in the same quarter a year ago a decrease compare to $-0.28 realized in previous quarter.

*first quarter of 2023*
Earnings Per Share	Revenues
$ -0.37	$ 6 Mill
$-0.60	$-60M -90.49 %

Telesis Bio Inc 's Revenue fell by -90.49 % in first quarter of 2023 (Mar 31 2023) year on year, to $6 million and declined by -33.3 % sequentially.

Telesis Bio Inc is Expected to report next financial results on March 21, 2024.

More on TBIO's Income Statement

TBIO's NET INCOME

Telesis Bio Inc 's in thefirst quarter of 2023 recorded net loss of $-11.119 million, compare to net income of $17.344 million achieved in III. Quarter a year ago.

Sequentially net loss advanced

More on TBIO's Growth

Telesis Bio Inc Inventories
In Mar 31 2023 company's net cash and cash equivalents decreased by $-7 million, capital expenditures grew by -52.43%, to $0 millions compare to same quarter a year ago and rose by -55.20% from IV. Quarter (Dec 31 2022).

More on TBIO's Cash flow Statement

Earnings quality

Telesis Bio Inc does not pay out common stock dividend.

In trailing twelve-month period Telesis Bio Inc payed $ -1.68 cash per share, on a free-cash flow basis .

Book value grew by 109.71 % sequentially to $1.23 per share.
Tangible Book value grew to $ 0.67 per share from $ 0.38.

Company repurchased 49.44 million shares or 62.50 % in Mar 31 2023.
Debt Coverage Ratio was 2.29.

• More on TBIO's Dividends

Market Capitalization (Millions)	44
Shares Outstanding (Millions)	30
Total Debt (Millions $)	20
Revenue (TTM) (Millions $)	123
Net Income (TTM) (Millions $)	24
Cash Flow (TTM) (Millions $)	-59
Capital Exp. (TTM) (Millions $)	-5
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	11

Earnings quality

Telesis Bio Inc does not pay out common stock dividend.

In trailing twelve-month period Telesis Bio Inc had negative $ -1.68 cash flow per share, on a free-cash flow basis .

Book value grew by 109.71 % sequentially to $1.23 per share.
Tangible Book value grew to $ 0.67 per share from $ 0.38.

Company repurchased 49.44 million shares or 62.50 % in Mar 31 2023.
Debt Coverage Ratio was 2.29.

• More on TBIO's Balance Sheets

Market Capitalization (Millions)	44
Shares Outstanding (Millions)	30
Total Debt (Millions $)	20
Revenue (TTM) (Millions $)	123
Net Income (TTM) (Millions $)	24
Cash Flow (TTM) (Millions $)	-59
Capital Exp. (TTM) (Millions $)	-5
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	11

Telesis Bio Inc

TBIO's Financial Statements and Analysis